Search

9 May 2022: KARPAS 241 Human Monoblastic cell line useful in oncology research, developed at the University of Cambridge.

11 Apr 2022: Over the past year, the team has identified and reviewed 55 new opportunities and presented 13 to the Ceres Investment Committee.

9 May 2022: COBRAS Concrete Bridge Assessment Program is a yield-line analysis software for assessing the ultimate load capacity of concrete structures.

19 Sep 2022: We are excited to pioneer a new era in the treatment of diseases related to mitochondrial dysfunction. ... The expertise we have assembled and the platform technologies we have created will allow new inroads into treating both rare genetic diseases as

11 Apr 2022: New Zealand Family Cancer Services. BOADICEA being incorporated within BRRISK helps time-poor GP’s to stratify patients according to risk. ... Oncoplastic Breast Surgeon, Auckland, New Zealand. Pause. Play. If you would like more information on BOADICEA

9 May 2022: Questionnaire developed at the University of Cambridge and validated for use with reception- and nursery-aged children.

4 Oct 2022: The finalists’ pitches will be judged on a number of criteria, including each business’s competitive position, the potential for new business creation, and each team’s collective skill set.

11 Apr 2022: Evidence included scientific papers, government reports, and local news articles. The close collaboration with local expert teams throughout the process brought great depth of knowledge, and ensured that visions remained focused

9 May 2022: Hybridoma cell line producing YTH 53.1 antibodies raised against human CD59 which are rat monoclonal antibodies of the IgG2b isotype.

11 Nov 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 11 November 2022. Sparxell wins the 2022 Chris Abell Postdoc Business Plan Competition. Share:. Sparxell has won the Chris Abell Postdoc Business Plan Competition 2022, securing the £20

9 May 2022: Hybridoma cell line producing YTH 30.15 antibodies raised against human CD7 which are rat monoclonal antibodies of the IgG2b isotype.

11 Apr 2022: HappyShield provides a barrier from splashes and sprays of infected bodily fluids and can be cleaned and reused indefinitely.

17 Aug 2022: In addition, applicants will benefit from even more support with our new summer programme, which offers an additional series of activities through a blend of round table discussions, one-to-one

9 May 2022: Hybridoma cell line producing YTH 24.5 antibodies raised against human CD45 which are rat monoclonal antibodies of the IgG2b isotype.

11 Apr 2022: so-called Valley of Death, the interval when promising new research can wither and die for lack of funding. ... Next steps. Apollo is now advancing into clinical development as well as identifying new programmes.

9 May 2022: Hybridoma cell line producing YTH 81.5 antibodies raised against human CD11a which are rat monoclonal antibodies of the IgG2a isotype.

28 Apr 2022: and Macmillan Cancer Support, in order to define a new clinical pathway for treating suspected neutropenic sepsis, and to ensure people living with disease continue to be at the heart of

9 May 2022: Hybridoma cell line producing YFC 120.5 antibodies raised against human CD16 which are rat monoclonal antibodies of the IgG2b isotype.

11 Apr 2022: We ran a knowledge exchange programme on research commercialisation for three southern African universities in 2019.

9 May 2022: CHO cells transfected to express human FcgRlla allotype 131R as a transmembrane protein with its native intracellular domain.